Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Companies / China

AstraZeneca Invests In Chinese R&D

May 2006 | FDI Alert

AstraZeneca is planning to invest US$100mn on R&D in China over the next three years. The AstraZeneca Innovation Centre China is expected to be operational by 2009, and will match the firm's global R&D priorities, which focus on discovering new treatments for cancer.

Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.

[
: *
[
: *

Forgotten your password?

If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.

If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.

Related Insight Articles
Novartis Plans New R&D Centre

Companies / China Swiss drugmaker Novartis is planning to invest US$100mn in a research centre in Shanghai, in a vote of confidence for the country's emerging scientific infrastructure. Construction on the 38,000 square-metre...
November 2006
J&J Targets Medical Device Sector

Companies / China US drugmaker and healthcare company Johnson & Johnson (J&J) has broken ground on a new US$47mn medical device manufacturing facility in China. The 16,000-square metre factory, which is located...
September 2006
Cipla Mulls Chinese Biotech Bid

Companies / China Indian drugmaker Cipla is reported to be in talks with a number of biotechnology firms in China with the aim of acquiring manufacturing facilities. The company raised US$170mn through global depository...
September 2006
Wyeth Opens China Trial Centre

Companies / China Market observers recently speculated that China and India will jointly capture a share of the global outsourced drug discovery market worth US$19.8bn by
March 2006
Baxter Expands Chinese Production

Companies / China US-based Baxter International to invest US$60mn over the next five years to expand production capacity at its four manufacturing plants in
March 2006


All material on this site is protected by international copyright laws and use of this site is subject to our Terms & Conditions.
© 2009 Business Monitor International Ltd
Site powered by WORKSsitebuilder CMS